6.69
price up icon0.90%   0.06
after-market After Hours: 6.63 -0.06 -0.90%
loading
Avalo Therapeutics Inc stock is traded at $6.69, with a volume of 112.66K. It is up +0.90% in the last 24 hours and up +39.67% over the past month. Avalo Therapeutics Inc is a clinical-stage biotechnology company focused on the treatment of immune dysregulation. The company's asset is AVTX-009, an anti-IL-1B monoclonal antibody ("mAb"), targeting inflammatory diseases. Avalo's pipeline also includes quisovalimab (anti-LIGHT mAb) and AVTX-008 (BTLA agonist fusion protein).
See More
Previous Close:
$6.63
Open:
$6.7
24h Volume:
112.66K
Relative Volume:
1.22
Market Cap:
$72.44M
Revenue:
$1.93M
Net Income/Loss:
$-7.96M
P/E Ratio:
-0.00189
EPS:
-3530.8178
Net Cash Flow:
$-36.78M
1W Performance:
+7.04%
1M Performance:
+39.67%
6M Performance:
-11.27%
1Y Performance:
-42.53%
1-Day Range:
Value
$6.3551
$6.75
1-Week Range:
Value
$6.345
$7.15
52-Week Range:
Value
$3.39
$16.00

Avalo Therapeutics Inc Stock (AVTX) Company Profile

Name
Name
Avalo Therapeutics Inc
Name
Phone
410-522-8707
Name
Address
1500 LIBERTY RIDGE DRIVE, WAYNE
Name
Employee
23
Name
Twitter
Name
Next Earnings Date
2024-11-07
Name
Latest SEC Filings
Name
AVTX's Discussions on Twitter

Compare AVTX with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
AVTX
Avalo Therapeutics Inc
6.69 71.79M 1.93M -7.96M -36.78M -3,530.82
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
469.65 121.28B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
563.10 60.96B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
328.81 42.77B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
591.99 36.21B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
291.47 32.08B 3.81B -644.79M -669.77M -6.24

Avalo Therapeutics Inc Stock (AVTX) Upgrades & Downgrades

Date Action Analyst Rating Change
Jun-02-25 Resumed H.C. Wainwright Buy
Mar-25-25 Initiated Jefferies Buy
Mar-25-25 Initiated Stifel Buy
Feb-28-25 Initiated Piper Sandler Overweight
Feb-21-25 Initiated Wedbush Outperform
Dec-19-24 Initiated BTIG Research Buy
Oct-24-24 Initiated H.C. Wainwright Neutral
Apr-16-24 Upgrade Oppenheimer Perform → Outperform
Sep-24-21 Initiated RBC Capital Mkts Outperform
View All

Avalo Therapeutics Inc Stock (AVTX) Latest News

pulisher
05:08 AM

What drives Avalo Therapeutics Inc. stock priceHigh-yield investments - PrintWeekIndia

05:08 AM
pulisher
Jul 24, 2025

Avalo Therapeutics Inc. Stock Analysis and ForecastAccelerated capital growth - PrintWeekIndia

Jul 24, 2025
pulisher
Jul 24, 2025

When is the best time to buy Avalo Therapeutics Inc. stockExponentially increasing returns - jammulinksnews.com

Jul 24, 2025
pulisher
Jul 23, 2025

What analysts say about Avalo Therapeutics Inc. stockUnmatched market gains - Autocar Professional

Jul 23, 2025
pulisher
Jul 22, 2025

Is Avalo Therapeutics Inc. a good long term investmentUnmatched market performance - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

Stifel reiterates Buy rating on Avalo Therapeutics stock, maintains $36 target By Investing.com - Investing.com South Africa

Jul 22, 2025
pulisher
Jul 22, 2025

Stifel reiterates Buy rating on Avalo Therapeutics stock, maintains $36 target - Investing.com Australia

Jul 22, 2025
pulisher
Jul 21, 2025

Avalo Therapeutics Soars 10.66% on Bullish Sentiment - AInvest

Jul 21, 2025
pulisher
Jul 18, 2025

Avalo Therapeutics (AVTX) Soars 10.42% on Analyst Upgrade - AInvest

Jul 18, 2025
pulisher
Jul 18, 2025

What makes Avalo Therapeutics Inc. stock attractive to long term investorsBalanced Risk Reward Portfolio - Newser

Jul 18, 2025
pulisher
Jul 18, 2025

Does Avalo Therapeutics Inc. stock pay reliable dividendsReal Time Alert Service - Newser

Jul 18, 2025
pulisher
Jul 18, 2025

What institutions are buying Avalo Therapeutics Inc. stock nowGrowth Optimized Stock Radar - beatles.ru

Jul 18, 2025
pulisher
Jul 15, 2025

What makes Avalo Therapeutics Inc. stock price move sharplyBreakout Confirmation Tool - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

Why Avalo Therapeutics Inc. stock attracts strong analyst attentionIntraday Trade Ideas - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

How Avalo Therapeutics Inc. stock performs during market volatilityVolume Spike Monitors - Newser

Jul 15, 2025
pulisher
Jul 09, 2025

(AVTX) Investment Analysis and Advice - news.stocktradersdaily.com

Jul 09, 2025
pulisher
Jul 04, 2025

Avalo Adds Dr. Rita Jain to Board as LOTUS Trial Advances - MSN

Jul 04, 2025
pulisher
Jul 03, 2025

Avalo Therapeutics, Inc. (NASDAQ:AVTX) Receives Consensus Recommendation of “Buy” from Brokerages - Defense World

Jul 03, 2025
pulisher
Jun 29, 2025

How To Trade (AVTX) - news.stocktradersdaily.com

Jun 29, 2025
pulisher
Jun 26, 2025

15 Best Growth Stocks to Invest in for the Next 5 Years - Insider Monkey

Jun 26, 2025
pulisher
Jun 23, 2025

Avalo Therapeutics to Participate in Upcoming Investor Conferences - GlobeNewswire

Jun 23, 2025
pulisher
Jun 20, 2025

Avalo Therapeutics Highlights Potential of AVTX-009 in HS - TipRanks

Jun 20, 2025
pulisher
Jun 18, 2025

(AVTX) Long Term Investment Analysis - news.stocktradersdaily.com

Jun 18, 2025
pulisher
Jun 18, 2025

Avalo Therapeutics appoints Dr. Rita Jain to board of directors By Investing.com - Investing.com Nigeria

Jun 18, 2025
pulisher
Jun 18, 2025

Avalo Therapeutics (AVTX) Welcomes New Board Member | AVTX Stock News - GuruFocus

Jun 18, 2025
pulisher
Jun 18, 2025

Avalo Therapeutics Announces Appointment of Rita Jain, M.D. to Board of Directors - GlobeNewswire

Jun 18, 2025
pulisher
Jun 18, 2025

Avalo Therapeutics Announces Appointment of Rita Jain, M.D. to B - GuruFocus

Jun 18, 2025
pulisher
Jun 18, 2025

Avalo Therapeutics appoints Dr. Rita Jain to board of directors - Investing.com

Jun 18, 2025
pulisher
Jun 15, 2025

Avalo Therapeutics, Inc. (NASDAQ:AVTX) Short Interest Down 45.8% in May - Defense World

Jun 15, 2025

Avalo Therapeutics Inc Stock (AVTX) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$23.40
price down icon 0.97%
$36.67
price up icon 0.22%
$103.95
price up icon 0.42%
$28.67
price up icon 3.99%
$115.31
price up icon 0.65%
biotechnology ONC
$291.47
price down icon 1.68%
Cap:     |  Volume (24h):